Mark Thierer - Net Worth and Insider Trading
Mark Thierer Net Worth
The estimated net worth of Mark Thierer is at least $3 Million dollars as of 2024-05-05. Mark Thierer is the Interim Chief Exec Officer of Dentsply Sirona Inc and owns about 119,270 shares of Dentsply Sirona Inc (XRAY) stock worth over $3 Million. Mark Thierer is also the President, Physicians Interact of Veradigm Inc and owns about 15,600 shares of Veradigm Inc (MDRX) stock worth over $120,120. Details can be seen in Mark Thierer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Thierer has not made any transactions after 2017-11-13 and currently still holds the listed stock(s).
Transaction Summary of Mark Thierer
Mark Thierer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Thierer owns 8 companies in total, including Xeris Biopharma Holdings Inc (XERS) , Discover Financial Services (DFS) , and Dentsply Sirona Inc (XRAY) among others .
Click here to see the complete history of Mark Thierer’s form 4 insider trades.
Insider Ownership Summary of Mark Thierer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2020-06-04 | director |
| DFS | Discover Financial Services | 2020-05-14 | director |
| XRAY | Dentsply Sirona Inc | 2017-11-13 | Interim Chief Exec Officer |
 | | 2006-06-02 | President & Phys. Inter. Group |
| | 2020-12-10 | director |
| | 2021-12-03 | director |
| | 2020-12-10 | director |
| | 2021-12-03 | director |
Mark Thierer Latest Holdings Summary
Mark Thierer currently owns a total of 2 stocks. Among these stocks, Mark Thierer owns 119,270 shares of Dentsply Sirona Inc (XRAY) as of November 13, 2017, with a value of $3 Million and a weighting of 96.56%. Mark Thierer also owns 15,600 shares of Veradigm Inc (MDRX) as of June 2, 2006, with a value of $120,120 and a weighting of 3.44%.
Latest Holdings of Mark Thierer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XRAY | Dentsply Sirona Inc | 2017-11-13 | 119,270 | 28.29 | 3,374,148 |
| MDRX | Veradigm Inc | 2006-06-02 | 15,600 | 7.70 | 120,120 |
Holding Weightings of Mark Thierer
Mark Thierer Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Thierer has made a total of 0 transactions in Dentsply Sirona Inc (XRAY) over the past 5 years. The most-recent trade in Dentsply Sirona Inc is the acquisition of 77,000 shares on November 13, 2017, which cost Mark Thierer around $5 Million.
According to the SEC Form 4 filings, Mark Thierer has made a total of 0 transactions in Veradigm Inc (MDRX) over the past 5 years. The most-recent trade in Veradigm Inc is the sale of 135,216 shares on June 2, 2006, which brought Mark Thierer around $2 Million.
Insider Trading History of Mark Thierer
- 1
Mark Thierer Trading Performance
GuruFocus tracks the stock performance after each of Mark Thierer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Thierer is -13.39%. GuruFocus also compares Mark Thierer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Thierer within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Thierer's insider trading performs compared to the benchmark.
Performance of Mark Thierer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.4 | | | | | |
| Relative Return to S&P 500(%) | -2.62 | | | | | |
Mark Thierer Ownership Network
Mark Thierer Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Mark Thierer is the director of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Mark Thierer made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 30,000 shares made by Paul R Edick , a net purchase of 11,000 shares made by John P. Schmid , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 4,500 shares, with a net purchase of 4,500 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 110,579 shares were bought by its insiders, resulting in a net purchase of 110,579 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Mark Thierer Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Thierer. You might contact Mark Thierer via mailing address: Dentsply Sirona Inc, 221 W Philadelphia St, Ste 60w, York Pa 17401-2991.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
